Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Small amounts of DNA can be found in the hair shaft, especially near the root, but it decreases with hair treatments and washing.

Some cancer treatments can cause abnormal fine hair growth.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Genetic factors affecting skin health and body weight may increase the risk of dermatophytosis.

Inflammatory acne damages skin stem cells and reduces their growth, leading to atrophic acne scars.

Chronic bacterial infections of hair follicles can cause ongoing skin inflammation.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The patient with Ankylosing Spondylitis had shoulder joint damage and bone changes.

Different genes are linked to various types of hair loss.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.